Eli Lilly (United States)

关于

暂无简介。

研究焦点

主要成就

代表论文

1. 1
   An automated robotic platform for rapid profiling oligosaccharide analysis of monoclonal antibodies directly from cell culture

   46 次引用 · 2013
2. 2
   A Platform for Characterizing Therapeutic Monoclonal Antibody Breakdown Products by 2D Chromatography and Top-Down Mass Spectrometry

   37 次引用 · 2012
3. 3
   High‐throughput mAb expression and purification platform based on transient <scp>CHO</scp>

   29 次引用 · 2014
4. 4
   Configuring Radioligand Receptor Binding Assays for HTS Using Scintillation Proximity Assay Technology

   21 次引用 · 2003
5. 5
   Automating combinatorial chemistry: A primer on benchtop robotic systems

   19 次引用 · 1996
6. 6
   Open PHACTS computational protocols for <i>in silico</i> target validation of cellular phenotypic screens: knowing the knowns

   18 次引用 · 2016
7. 7
   A Decoupled Automation Platform for Hydrogen/Deuterium Exchange Mass Spectrometry Experiments

   18 次引用 · 2019
8. 8
   Recent trends in laboratory automation in the pharmaceutical industry.

   12 次引用 · 2001
9. 9
   Opportunities and Challenges for Statisticians in Advanced Pharmaceutical Manufacturing

   5 次引用 · 2019
10. 10
    Glucose Stimulates the Tyrosine Phosphorylation of Crk-associated Substrate in Pancreatic β-Cells

    5 次引用 · 2003

教职员与研究人员

…